Jyong Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 24, 2026	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Debt / Equity Ratio	-0.50	-0.49	-0.48	-0.51	-0.67
Debt / EBITDA Ratio	-6.91	-6.25	-5.27	-5.17	-5.54
Debt / FCF Ratio	-4.25	-6.42	-4.43	-5.56	-11.01
Quick Ratio	0.01	0.12	0.18	0.09	0.89
Current Ratio	0.02	0.13	0.19	0.42	1.08
Return on Equity (ROE)	11.55%	13.81%	25.04%	19.74%	9.98%
Return on Assets (ROA)	-35.93%	-32.92%	-31.13%	-21.58%	-19.05%
Return on Invested Capital (ROIC)	-49.41%	-51.31%	-42.37%	-32.85%	-35.62%
Return on Capital Employed (ROCE)	45.88%	54.99%	552.54%	-47.12%	-34.62%

Updated Jun 30, 2024. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q